G1 Therapeutics, Inc. Patent Application Trends in 2024
Jump to navigation
Jump to search
Contents
G1 Therapeutics, Inc. Patent Filing Activity
G1 Therapeutics, Inc. patent applications in 2024
Top 10 Technology Areas
- C07D487/20 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 2 patents
- Example: 20240109906. CDK INHIBITORS simplified abstract (G1 Therapeutics, inc.)
- C07D241/38 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: [[20240199556. Synthesis of 1,4-Diazaspiro[5.5]Undecan-3-One simplified abstract (G1 Therapeutics, Inc.)]]
- C07C219/18 (ACYCLIC OR CARBOCYCLIC COMPOUNDS)
- Count: 1 patents
- Example: [[20240199556. Synthesis of 1,4-Diazaspiro[5.5]Undecan-3-One simplified abstract (G1 Therapeutics, Inc.)]]
- C07D239/47 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: [[20240199556. Synthesis of 1,4-Diazaspiro[5.5]Undecan-3-One simplified abstract (G1 Therapeutics, Inc.)]]
- A61K31/519 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- A61K31/4375 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- A61K47/68037 ({Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates})
- A61K47/6851 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- A61P35/00 (Antineoplastic agents)
- C07K16/30 (PEPTIDES (peptides in foodstuffs)
Emerging Technology Areas
- C07D487/04 (Ortho-condensed systems)
- C07D519/00 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240109906. CDK INHIBITORS simplified abstract (G1 Therapeutics, inc.)
- C07D498/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240109906. CDK INHIBITORS simplified abstract (G1 Therapeutics, inc.)
- A61K31/527 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20240109906. CDK INHIBITORS simplified abstract (G1 Therapeutics, inc.)
- A61K31/499 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20240109906. CDK INHIBITORS simplified abstract (G1 Therapeutics, inc.)
- C07D487/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240109906. CDK INHIBITORS simplified abstract (G1 Therapeutics, inc.)
- C07K16/30 (PEPTIDES (peptides in foodstuffs)
- A61P35/00 (Antineoplastic agents)
- A61K47/6851 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- A61K47/68037 ({Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates})
Top Inventors
- Stephen E. Schneider of Raleigh NC (US) (1 patent)
- Hannah White of Chapel Hill NC (US) (1 patent)
- Thomas Fessard (1 patent)
- Sagar Beldar (1 patent)
- Andrew Beelen of Cary NC (US) (1 patent)
- Rajesh Kumar Malik of Chapel Hill NC (US) (1 patent)
- John Seung-Hoon Yi of Durham NC (US) (1 patent)
- Curt Douglas Wolfgang of Durham NC (US) (1 patent)
- Francis X. Tavares of Durham NC (US) (1 patent)
- Jay C. Strum of Hillsborough NC (US) (1 patent)